Could stem cells be the key to saving lives from Sepsis-Induced lung failure?

NCT ID NCT07439848

Recruiting now Disease control Sponsor: PT. Prodia Stem Cell Indonesia Source: ClinicalTrials.gov ↗

First seen Feb 28, 2026 · Last updated May 23, 2026 · Updated 15 times

Summary

This study tests whether adding umbilical cord stem cells (and their secretions) to standard care can help people with severe lung injury from pneumonia-related sepsis recover faster and lower the risk of death. About 15 adults aged 40 and older with severe ARDS will be randomly assigned to receive either standard care, stem cells, or stem cells plus their secretions. The goal is to see if these treatments improve lung function and reduce organ failure.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE RESPIRATORY DISTRESS SYNDROME are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

RSPAD Gatot Soebroto
RECRUITING

Jakarta Pusat, DKI Jakarta, 10410, Indonesia

Contact

Conditions

Explore the condition pages connected to this study.

ACUTE RESPIRATORY DISTRESS SYNDROME